OPSIS THERAPEUTICS Trademark

Trademark Overview

On Monday, September 26, 2016, a trademark application was filed for OPSIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OPSIS THERAPEUTICS trademark a serial number of 87182705. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 3, 2020. This trademark is owned by Opsis Therapeutics, LLC. The OPSIS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Cell based preparations derived from human stem cells for treatment of ocular disorders; cell based products derived from human stem cells useful for treatment of ocular disorders, namely, living tissue grafts for surgical implantation

Cell based products derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation
opsis therapeutics

General Information

Serial Number87182705
Word MarkOPSIS THERAPEUTICS
Filing DateMonday, September 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 3, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesCell based preparations derived from human stem cells for treatment of ocular disorders; cell based products derived from human stem cells useful for treatment of ocular disorders, namely, living tissue grafts for surgical implantation
Goods and ServicesCell based products derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, March 8, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOpsis Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMadison, WI 53711
Party NameOpsis Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMadison, WI 53711

Trademark Events

Event DateEvent Description
Monday, August 3, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 3, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2019EXTENSION 5 GRANTED
Friday, November 22, 2019EXTENSION 5 FILED
Monday, December 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 22, 2019TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019EXTENSION 4 GRANTED
Monday, May 20, 2019EXTENSION 4 FILED
Monday, May 20, 2019TEAS EXTENSION RECEIVED
Saturday, December 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 27, 2018EXTENSION 3 GRANTED
Thursday, December 27, 2018EXTENSION 3 FILED
Thursday, December 27, 2018TEAS EXTENSION RECEIVED
Saturday, June 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 14, 2018EXTENSION 2 GRANTED
Thursday, June 14, 2018EXTENSION 2 FILED
Thursday, June 14, 2018TEAS EXTENSION RECEIVED
Thursday, December 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2017EXTENSION 1 GRANTED
Tuesday, December 12, 2017EXTENSION 1 FILED
Tuesday, December 12, 2017TEAS EXTENSION RECEIVED
Tuesday, June 27, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 24, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 13, 2017EXAMINER'S AMENDMENT ENTERED
Monday, March 13, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 13, 2017EXAMINERS AMENDMENT E-MAILED
Monday, March 13, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 6, 2017COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Thursday, January 5, 2017ASSIGNED TO LIE
Thursday, January 5, 2017NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, January 5, 2017EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, January 5, 2017EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, January 3, 2017ASSIGNED TO EXAMINER
Thursday, September 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics opsis cells treatment cell disorders stem ocular based human derived from